Safran H - Search Results

1

Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study.

Winer ES, Safran H, Karaszewska B, Richards DA, Hartner L, Forget F, Ramlau R, Kumar K, Mayer B, Johnson BM, Messam CA, Mostafa Kamel Y. Winer ES, et al. Among authors: safran h. Cancer Med. 2015 Jan;4(1):16-26. doi: 10.1002/cam4.326. Epub 2014 Aug 28. Cancer Med. 2015. PMID: 25165041 Free PMC article. Clinical Trial.

2

Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.

Choy H, Safran H. Choy H, et al. Among authors: safran h. Semin Oncol. 1995 Aug;22(4 Suppl 9):55-7. Semin Oncol. 1995. PMID: 7644929 Clinical Trial.

3

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.

Choy H, Akerley W, Safran H, Clark J, Rege V, Papa A, Glantz M, Puthawala Y, Soderberg C, Leone L. Choy H, et al. Among authors: safran h. J Clin Oncol. 1994 Dec;12(12):2682-6. doi: 10.1200/JCO.1994.12.12.2682. J Clin Oncol. 1994. PMID: 7989944 Clinical Trial.

4

p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma.

Safran H, King T, Choy H, Gollerkeri A, Kwakwa H, Lopez F, Cole B, Myers J, Tarpey J, Rosmarin A. Safran H, et al. Cancer. 1996 Sep 15;78(6):1203-10. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1203::AID-CNCR6>3.0.CO;2-A. Cancer. 1996. PMID: 8826941 Clinical Trial.

5

Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial.

Akerley W, Choy H, Safran H, Sikov W, Rege V, Sambandam S, Wittels E. Akerley W, et al. Among authors: safran h. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-10-S12-13. Semin Oncol. 1997. PMID: 9331112 Clinical Trial.

6

Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report.

Akerley W, Sikov WM, Cummings F, Safran H, Strenger R, Marchant D. Akerley W, et al. Among authors: safran h. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-87-S17-90. Semin Oncol. 1997. PMID: 9374102 Clinical Trial.

7

Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results.

Chougule P, Wanebo H, Akerley W, McRae R, Nigri P, Leone L, Safran H, Ready N, Koness RJ, Radie-Keane K, Cole B. Chougule P, et al. Among authors: safran h. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-57-S19-61. Semin Oncol. 1997. PMID: 9427268 Clinical Trial.

8

Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study.

Chougule PB, Akhtar MS, Akerley W, Ready N, Safran H, McRae R, Nigri P, Bellino J, Koness J, Radie-Keane K, Wanebo H. Chougule PB, et al. Among authors: safran h. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):58-63. Semin Radiat Oncol. 1999. PMID: 10210541 Clinical Trial.

9

p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma.

King TC, Akerley W, Fan AC, Moore T, Mangray S, Hsiu Chen M, Safran H. King TC, et al. Among authors: safran h. Cancer. 2000 Aug 15;89(4):769-73. doi: 10.1002/1097-0142(20000815)89:4<769::aid-cncr8>3.0.co;2-6. Cancer. 2000. PMID: 10951339

10

Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer.

Safran H, Gaissert H, Akerman P, Hesketh PJ, Chen MH, Moore T, Koness J, Graziano S, Wanebo HJ. Safran H, et al. Cancer Invest. 2001;19(1):1-7. doi: 10.1081/cnv-100000068. Cancer Invest. 2001. PMID: 11291548 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters